Endoscope-Assisted Partial Mastectomy

Chapter

Abstract

Breast-conserving therapy (BCT) is currently the mainstream treatment for stage I and stage II breast cancer. Two techniques are available for BCT: the conventional conservative method (CCM) and endoscopic surgery. Endoscopic surgery has the advantage of improving cosmetic outcome and early postoperative quality of life, and alleviating postoperative pain.

Keywords

Dead Space Cosmetic Outcome Indigo Carmine Pectoralis Major Muscle Mesh Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Al-Ghazal SK, Fallowfield L, Blamey RW. Does cosmetic outcome from treatment of primary breast cancer influence psychosocial morbidity? Eur J Surg Oncol. 1999;25:571–3.CrossRefPubMedGoogle Scholar
  2. 2.
    Clough KB, Nos C, Salmon RJ, Soussaline M, Durand JC. Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumors. Plast Reconstr Surg. 1995;96:363–70.CrossRefPubMedGoogle Scholar
  3. 3.
    Rose MA, Olivotto I, Cady B, Koufman C, Osteen R, Silver B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg. 1989;124:153–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Liljegren G, Holmberg L, Westman G. The cosmetic outcome in early breast cancer treated with sector resection with or without radiotherapy. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer. 1993;29A:2083–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Sarin R, Dinshaw KA, Shrivastava SK, Sharma V, Deore SM. Therapeutic factors influencing the cosmetic outcome and late complications in the conservative management of early breast cancer. Int J Radiat Oncol Biol Phys. 1993;27:285–92.CrossRefPubMedGoogle Scholar
  6. 6.
    Van Limbergen E, Rijnders A, van der Schueren E, Lerut T, Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol. 1989;16:253–67.CrossRefPubMedGoogle Scholar
  7. 7.
    Yamagata M, Iwai S. Endoscopic treatment for breast cancer [in Japanese]. J Jpn Soc Endosc Surg. 1997;2:272–7.Google Scholar
  8. 8.
    Takemoto N, Koyanagi A, Yamamoto H. Comparison between endoscope-assisted partial mastectomy with filling of dead space using absorbable mesh and conventional conservative method on cosmetic outcome in patients with stage I or II breast cancer. Surg Laparosc Endosc Percutan Tech. 2012;22:68–72.CrossRefPubMedGoogle Scholar
  9. 9.
    Hernanz F, Regaño S, Redondo-Figuero C, Orallo V, Erasun F, Gómez-Fleitas M. Oncoplastic breast-conserving surgery: analysis of quadrantectomy and immediate reconstruction with latissimus dorsi flap. World J Surg. 2007;31:1934–40.CrossRefPubMedGoogle Scholar
  10. 10.
    Thomson HJ, Potter S, Greenwood RJ, Bahl A, Barker J, Cawthorn SJ, Winters ZE. A prospective longitudinal study of cosmetic outcome in immediate latissimus dorsi breast reconstruction and the influence of radiotherapy. Ann Surg Oncol. 2008;15:1081–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Ho WS, Ying SY, Chan AC. Endoscopic-assisted subcutaneous mastectomy and axillary dissection with immediate mammary prosthesis reconstruction for early breast cancer. Surg Endosc. 2002;16:302–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Sanuki J, Fukuma E. Volume replacement for correcting breast deformity after breast conserving surgery [in Japanese]. Surgery. 2007;69:2007–10.Google Scholar
  13. 13.
    Sanuki J, Fukuma E, Wadamori K, Higa K, Sakamoto N, Tsunoda Y. Volume replacement with polyglycolic acid mesh for correcting breast deformity after endoscopic conservative surgery. Clin Breast Cancer. 2005;6:175.CrossRefPubMedGoogle Scholar
  14. 14.
    Takemoto N, Koyanagi A, Yamamoto H, Shimura K, Fujii R. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in patients with stage I or II breast cancer. Ann Oncol. 2014;25 Suppl 1:i3.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Nobuyuki Takemoto
    • 1
  • Ai Koyanagi
    • 2
  • Hiroshi Yamamoto
    • 3
  1. 1.Department of Breast and Endocrine SurgeryJapan Medical Alliance, Higashi Saitama General HospitalSatteJapan
  2. 2.Research and Development Unit, Parc Sanitari Sant Joan de DéuFundació Sant Joan de Déu, Dr. Antoni PujadasBarcelonaSpain
  3. 3.Geriatric Health Service FacilityYokohama Brain and Spine Center, Japan Medical AllianceYokohamaJapan

Personalised recommendations